307 related articles for article (PubMed ID: 17352743)
21. Genome instability in progeria: when repair gets old.
Misteli T; Scaffidi P
Nat Med; 2005 Jul; 11(7):718-9. PubMed ID: 16015360
[No Abstract] [Full Text] [Related]
22. Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy.
Moulson CL; Go G; Gardner JM; van der Wal AC; Smitt JH; van Hagen JM; Miner JH
J Invest Dermatol; 2005 Nov; 125(5):913-9. PubMed ID: 16297189
[TBL] [Abstract][Full Text] [Related]
23. Pushing the envelope.
Leslie M
Sci Aging Knowledge Environ; 2006 May; 2006(9):nf14. PubMed ID: 16723635
[No Abstract] [Full Text] [Related]
24. Defective prelamin A processing resulting from LMNA or ZMPSTE24 mutations as the cause of restrictive dermopathy.
Levy N; López-Otín C; Hennekam RC
Arch Dermatol; 2005 Nov; 141(11):1473-4; author reply 1474. PubMed ID: 16301408
[No Abstract] [Full Text] [Related]
25. Prelamin A-mediated nuclear envelope dynamics in normal and laminopathic cells.
Lattanzi G
Biochem Soc Trans; 2011 Dec; 39(6):1698-704. PubMed ID: 22103510
[TBL] [Abstract][Full Text] [Related]
26. Emerin and the nuclear lamina in muscle and cardiac disease.
Holaska JM
Circ Res; 2008 Jul; 103(1):16-23. PubMed ID: 18596264
[TBL] [Abstract][Full Text] [Related]
27. Identification of cyclin D3 as a new interaction partner of lamin A/C.
Mariappan I; Gurung R; Thanumalayan S; Parnaik VK
Biochem Biophys Res Commun; 2007 Apr; 355(4):981-5. PubMed ID: 17321498
[TBL] [Abstract][Full Text] [Related]
28. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice.
Pendás AM; Zhou Z; Cadiñanos J; Freije JM; Wang J; Hultenby K; Astudillo A; Wernerson A; Rodríguez F; Tryggvason K; López-Otín C
Nat Genet; 2002 May; 31(1):94-9. PubMed ID: 11923874
[TBL] [Abstract][Full Text] [Related]
29. ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders.
Barrowman J; Michaelis S
Biol Chem; 2009 Aug; 390(8):761-73. PubMed ID: 19453269
[TBL] [Abstract][Full Text] [Related]
30. An antibody which specifically recognizes prelamin A but not mature lamin A: application to detection of blocks in farnesylation-dependent protein processing.
Sinensky M; Fantle K; Dalton M
Cancer Res; 1994 Jun; 54(12):3229-32. PubMed ID: 8205544
[TBL] [Abstract][Full Text] [Related]
31. Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cells.
Haraguchi T; Koujin T; Osakada H; Kojidani T; Mori C; Masuda H; Hiraoka Y
J Cell Sci; 2007 Jun; 120(Pt 12):1967-77. PubMed ID: 17519288
[TBL] [Abstract][Full Text] [Related]
32. Lamin A/C and polymeric actin in genome organization.
Ondrej V; Lukásová E; Krejcí J; Matula P; Kozubek S
Mol Cells; 2008 Oct; 26(4):356-61. PubMed ID: 18612243
[TBL] [Abstract][Full Text] [Related]
33. The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression.
Bertacchini J; Beretti F; Cenni V; Guida M; Gibellini F; Mediani L; Marin O; Maraldi NM; de Pol A; Lattanzi G; Cocco L; Marmiroli S
FASEB J; 2013 Jun; 27(6):2145-55. PubMed ID: 23430973
[TBL] [Abstract][Full Text] [Related]
34. Laminopathies: multisystem dystrophy syndromes.
Jacob KN; Garg A
Mol Genet Metab; 2006 Apr; 87(4):289-302. PubMed ID: 16364671
[TBL] [Abstract][Full Text] [Related]
35. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.
Agarwal AK; Fryns JP; Auchus RJ; Garg A
Hum Mol Genet; 2003 Aug; 12(16):1995-2001. PubMed ID: 12913070
[TBL] [Abstract][Full Text] [Related]
36. Tethering by lamin A stabilizes and targets the ING1 tumour suppressor.
Han X; Feng X; Rattner JB; Smith H; Bose P; Suzuki K; Soliman MA; Scott MS; Burke BE; Riabowol K
Nat Cell Biol; 2008 Nov; 10(11):1333-40. PubMed ID: 18836436
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle-dependent dynamics of nuclear pores: pore-free islands and lamins.
Maeshima K; Yahata K; Sasaki Y; Nakatomi R; Tachibana T; Hashikawa T; Imamoto F; Imamoto N
J Cell Sci; 2006 Nov; 119(Pt 21):4442-51. PubMed ID: 17074834
[TBL] [Abstract][Full Text] [Related]
38. Lamins are rapamycin targets that impact human longevity: a study in centenarians.
Lattanzi G; Ortolani M; Columbaro M; Prencipe S; Mattioli E; Lanzarini C; Maraldi NM; Cenni V; Garagnani P; Salvioli S; Storci G; Bonafè M; Capanni C; Franceschi C
J Cell Sci; 2014 Jan; 127(Pt 1):147-57. PubMed ID: 24155329
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice.
Oh YS; Kim DG; Kim G; Choi EC; Kennedy BK; Suh Y; Park BJ; Kim S
Aging Cell; 2010 Oct; 9(5):810-22. PubMed ID: 20726853
[TBL] [Abstract][Full Text] [Related]
40. Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts.
Zini N; Avnet S; Ghisu S; Maraldi NM; Squarzoni S; Baldini N; Lattanzi G
J Cell Biochem; 2008 Sep; 105(1):34-40. PubMed ID: 18442054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
